Partnerships

We are establishing relationships with mission-aligned partners to enable and scale commercial access to ultra-rare disease therapies

Orphan Therapies is building relationships with owners of commercial-stage ultra-rare disease treatments who are looking for a strong partner to take on the responsibility of making these treatments accessible to patients.

Our first commercial partnership, with Fondazione Telethon, has been put in place to enable patient access in the United States to a newly approved gene therapy. We are also collaborating with other partners to support manufacturing, distribution and access in a streamlined, cost-effective and compliant manner.

Please reach out to us at info@orphantxl.com if interested in partnering.